← Leaderboards
Alexander Gimelbrant
Dana-Farber Cancer Inst
$6,924,929
Attributed
$9,583,929
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,583,929 · 5
By mechanism
R01$8,257,202 · 2
R21$1,326,727 · 3
Top collaborators
- Matthew L Freedman4 shared
- Alexander Gusev4 shared
- Lauren Anne Weiss2 shared
- Jean Zhao2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Matthew L Freedman$13,331,420
- Xiaoyang Zhang$1,838,826
- David A Barbie$12,794,638
Others in their field
Top investigators on “Epigenetic Process”
- James E. Gern · University Of Wisconsin-Madison$115,652,679
- Richard A Gibbs · Baylor College Of Medicine$86,065,396
- Lisa P Jacobson · Johns Hopkins University$67,179,266
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$58,922,015
- Leonardo Trasande · New York University School Of Medicine$52,109,279
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$47,855,284
Research focus
Epigenetic ProcessAffectGenesAllelesLinkGenome-WideGeneticChromatinComplexGene ExpressionGenotypeTranscriptome SequencingIn VivoLeadDeep SequencingTraitVariantAllelic ImbalanceBiologyMolecularSamplingInnovationCodeGenetic Variant
Grant awards (15)
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$1,347,915
R01 · FY2025 · CA
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$640,260
R01 · FY2024 · CA
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$660,477
R01 · FY2023 · CA
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$693,457
R01 · FY2022 · CA
Mechanism and function of autosomal analog of X inactivation$974,914
R01 · FY2018 · GM · contact PI
Mechanism and function of autosomal analog of X inactivation$974,914
R01 · FY2017 · GM · contact PI
Mechanism and function of autosomal analog of X inactivation$974,914
R01 · FY2016 · GM · contact PI
Mechanism and function of autosomal analog of X inactivation$1,095,094
R01 · FY2015 · GM · contact PI
Assessing parent-of-origin transcriptional effects in Xenopus laevis$208,433
R21 · FY2015 · HD · contact PI
Epigenetic loss of heterozygosity in a recurrent neurodevelopmental CNV region$207,260
R21 · FY2015 · MH · contact PI
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect$184,327
R21 · FY2015 · CA · contact PI
Mechanism and function of autosomal analog of X inactivation$895,257
R01 · FY2014 · GM · contact PI
Assessing parent-of-origin transcriptional effects in Xenopus laevis$256,439
R21 · FY2014 · HD · contact PI
Epigenetic loss of heterozygosity in a recurrent neurodevelopmental CNV region$248,314
R21 · FY2014 · MH · contact PI
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect$221,954
R21 · FY2014 · CA · contact PI